MAGISTRONI, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.272
AS - Asia 8.162
EU - Europa 7.091
SA - Sud America 1.032
AF - Africa 192
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 12
Totale 30.794
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.974
SG - Singapore 2.733
CN - Cina 2.112
IT - Italia 1.987
GB - Regno Unito 1.270
DE - Germania 980
HK - Hong Kong 968
BR - Brasile 749
VN - Vietnam 749
SE - Svezia 690
FI - Finlandia 557
RU - Federazione Russa 413
BD - Bangladesh 348
FR - Francia 289
KR - Corea 248
UA - Ucraina 235
IN - India 190
CA - Canada 166
TR - Turchia 150
ID - Indonesia 134
BG - Bulgaria 113
AR - Argentina 112
NL - Olanda 111
JP - Giappone 102
MX - Messico 72
ES - Italia 67
IQ - Iraq 60
CZ - Repubblica Ceca 58
ZA - Sudafrica 56
AT - Austria 38
PL - Polonia 38
RO - Romania 38
AE - Emirati Arabi Uniti 36
CL - Cile 35
MA - Marocco 35
PK - Pakistan 35
MY - Malesia 33
EC - Ecuador 32
PH - Filippine 32
AU - Australia 31
VE - Venezuela 31
CO - Colombia 30
LT - Lituania 28
UZ - Uzbekistan 28
IE - Irlanda 27
CH - Svizzera 22
BE - Belgio 21
IL - Israele 21
IR - Iran 21
DZ - Algeria 19
SA - Arabia Saudita 18
JO - Giordania 17
TN - Tunisia 17
TW - Taiwan 16
PE - Perù 15
NP - Nepal 14
PY - Paraguay 14
TH - Thailandia 14
AZ - Azerbaigian 13
DK - Danimarca 12
EG - Egitto 12
SI - Slovenia 12
CR - Costa Rica 11
DO - Repubblica Dominicana 11
KZ - Kazakistan 11
AL - Albania 10
KE - Kenya 10
PT - Portogallo 10
LB - Libano 9
NG - Nigeria 9
EU - Europa 8
GR - Grecia 8
JM - Giamaica 8
KG - Kirghizistan 8
BY - Bielorussia 7
MD - Moldavia 7
OM - Oman 7
PA - Panama 7
RS - Serbia 7
UY - Uruguay 7
BH - Bahrain 6
BO - Bolivia 6
HR - Croazia 6
PS - Palestinian Territory 6
EE - Estonia 5
ET - Etiopia 5
HN - Honduras 5
MK - Macedonia 5
NO - Norvegia 5
SN - Senegal 5
CG - Congo 4
CI - Costa d'Avorio 4
GE - Georgia 4
MT - Malta 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
GA - Gabon 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
Totale 30.743
Salva come PNG Salva come JPEG
Città #
Singapore 1.966
Santa Clara 1.604
Ashburn 1.587
Fairfield 1.171
Hong Kong 939
San Jose 784
Chandler 721
Southend 699
Hefei 676
Woodbridge 632
Houston 549
Helsinki 465
Seattle 447
Wilmington 438
Nyköping 421
Cambridge 376
Jacksonville 358
Council Bluffs 335
London 333
Beijing 326
Ann Arbor 285
Dearborn 250
Los Angeles 250
Modena 250
Ho Chi Minh City 230
New York 227
Seoul 218
Chicago 210
The Dalles 199
Hanoi 186
Milan 148
Dallas 136
San Diego 123
Sofia 110
Princeton 106
Lauterbourg 101
Munich 100
Jakarta 95
Buffalo 90
Moscow 81
Shanghai 81
São Paulo 77
Tokyo 76
Salt Lake City 70
Eugene 69
Bologna 68
Rome 68
Redwood City 66
Orem 63
Frankfurt am Main 48
Toronto 48
Izmir 47
Brno 46
Parma 46
Phoenix 45
Des Moines 44
Tampa 42
Buenos Aires 41
Boardman 40
Chennai 40
Montreal 38
Da Nang 37
Guangzhou 37
Nuremberg 37
Amsterdam 36
Atlanta 34
Columbus 32
Elk Grove Village 31
Naples 29
Warsaw 29
San Francisco 28
Nanjing 27
Falls Church 26
Kent 26
Tashkent 26
Baghdad 25
Denver 25
Fremont 25
Haiphong 25
Brooklyn 24
Bari 23
Bremen 22
Norwalk 22
Rio de Janeiro 22
Turku 22
Wuhan 22
Stockholm 21
Mexico City 20
Redondo Beach 20
Dublin 19
Lancaster 19
Perugia 19
Reggio Emilia 19
Brussels 18
Johannesburg 18
Madrid 18
Turin 18
Vienna 18
Belo Horizonte 17
Paris 17
Totale 20.338
Salva come PNG Salva come JPEG
Nome #
CD133 and CD24 expression in renal tissue of patients affected by autosomal dominant polcystic kidney disease 414
Approccio pratico alla terapia del paziente affetto da Rene Policistico Autosomico Dominante 410
Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy 406
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers 398
Plasma exchange in acute and chronic hyperviscosity syndrome: a rheological approach and guidelines study 396
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 382
Tolvaptan in patients with autosomal dominant polycystic kidney disease 380
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? 365
Pregnancy and progression of IgA nephropathy: results of an Italian multicenter study 362
The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition 359
Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens 354
GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients 353
Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library 342
Confidence Calibration for Deep Renal Biopsy Immunofluorescence Image Classification 342
The definition of chronic kidney disease in a context of aging population 337
Evaluation of the Classification Accuracy of the Kidney Biopsy Direct Immunofluorescence through Convolutional Neural Networks 337
A pilot study to evaluate Tolerability and Safety of a Modified Atkins Diet in ADPKD patients 336
Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images 331
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy 329
Hypokalemia in Patients with COVID-19 326
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis 324
Corticosteroids in IgA nephropathy: A retrospective analysis from the VALIGA study 317
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e 310
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy 310
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) 306
Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment 304
ADPKD current management and ongoing trials 303
Peritoneal dialysis in the time of coronavirus disease 2019 303
Unified criteria for ultrasonographic diagnosis of ADPKD 300
COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine 297
Il rene policistico autosomico dominante (ADPKD): aspetti genetico-molecolari, clinici ed epidemiologici nella provincia di Modena. 294
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy 293
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): A case report 292
I polimorfismi del gene dell’enzima di conversione dell’angiotensina (ACE) nel rene policistico autosomico dominante (ADPKD) 287
Defective glycolysis and the use of 2-deoxy-d-glucose in polycystic kidney disease: from animal models to humans 287
Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease 284
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease 278
Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin 271
Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis 268
A validated model of disease progression in IgA nephropathy 267
Genome-wide association study identifies susceptibility loci for IgA nephropathy 267
Autosomal dominant polycystic kidney disease: from genes to cilium. 266
Advances in genetics of Immunoglobulin A Nephropathy. 266
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy 266
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments 266
HEMOREOLOGIC PROFILE OF KIDNEY TRANSPLANT RECIPIENTS: A ROLE IN CARDIOVASCULAR RISK? 263
Acid base disorders in patients with COVID-19 263
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 260
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial 260
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy 258
#5187 GREASE II: A PHASE II RANDOMIZED, 24-MONTH, PARALLEL-GROUP, SUPERIORITY STUDY TO EVALUATE THE EFFICACY OF A KETOGENIC DIET IN ADPKD PATIENTS 254
The MEST score provides earlier risk prediction in lgA nephropathy 254
Il Registro Italiano del Rene PolicisticoAutosomico Dominante 252
Geometry-independent assessment of renal volume in polycystic kidney disease from magnetic resonance imaging 252
[Screening for cerebral aneurysms in the ADPKD population: mandatory or potentially harmful?] 251
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 251
Methicillin-Resistant Staphylococcus aureus Peritonitis due to Hematogenous Dissemination from Central Venous Catheter in a Maintenance Dialysis Patient 251
Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease 249
Genetic variation of DKK3 may modify renal disease severity in ADPKD 245
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 241
COVID-19 Rapid Antigen Test Screening in Patients on Hemodialysis 240
Urine Proteome Analysis May Allow Non-Invasive Differential Diagnosis of Diabetic Nephropathy 239
Trattato di Medicina Interna : Le Sindromi Renali. 238
Interstitiome: a novel proteomic discipline applied to renal biopsy 236
Evaluation of coronary artery disease by multislice spiral computed tomography in dialysis patients 236
Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36 234
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 233
Tolvaptan: Clinical Evidence for Slowing the Progression of Autosomal Dominant Polycystic Kidney Disease 230
The underlying cause of kidney disease is often unknown in dialysis patients: a possible genomic approach 229
Monoclonal antibodies in nephrology: a delicate balance between curative potential, evidence of effectiveness, and toxicity 226
Reliability of Total Renal Volume Computation in Polycystic Kidney Disease From Magnetic Resonance Imaging 226
Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients. 219
Comment on the paper: 'novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease' 218
Combining telemedicine and in-person visits to deliver care to patients with severe chronic kidney disease (CKD): Lessons learned from COVID-19 217
TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes 217
Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study 214
Long-term effects of COVID-19 in a patient on maintenance dialysis 213
One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19 213
SARS-CoV-2 infection in dialysis patients in northern Italy: A single-centre experience 211
Artificial intelligence in glomerular diseases 210
Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study 206
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 205
Clinical Presentation, Renal Histopathological Findings, and Outcome in Patients with Monoclonal Gammopathy and Kidney Disease 204
Immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19 199
Weekly Rapid Antigen Test Screening for COVID-19 in Patients on Hemodialysis 197
Mycophenolate mofetil plus steroids compared to steroids alone in IgA nephropathy: a retrospective study 196
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 193
Monoclonal B lymphocytosis in a kidney transplant recipient 192
Hybrid dialysis: A promising strategy to reduce hospital access during the SARS-CoV-2 pandemic 191
MALATTIE DEL RENE, DELLE VIE URINARIE E DELL'APPARATO GENITALE MASCHILE : Le Nefropatie Glomerulari: glomerulonefriti primitive; glomerulonefriti secondarie 190
Which criteria should we use to end isolation in hemodialysis patients with COVID-19? 189
The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review 186
AKI in hospitalized patients with COVID-19: a single-center experience 186
Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 178
PATIENT AND TECHNIQUE SURVIVAL ON PERITONEAL DIALYSIS: A RETROSPECTIVE STUDY 178
Clinical diagnosis of Autosomal Dominant Polycystic Kidney Disease 176
[Genetics and genetic counseling] 171
[Diagnosis in Polycystic Kidney Disease] 171
Rethinking Chronic Kidney Disease in the Aging Population 170
A Review of the Imaging Techniques for Measuring Kidney and Cyst Volume in Establishing Autosomal Dominant Polycystic Kidney Disease Progression 169
Totale 26.535
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.047
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.342 180 206 223 166 100 131 130 138 260 189 371 248
2022/20232.439 234 247 209 211 215 332 95 249 258 57 142 190
2023/20241.848 101 113 127 227 280 174 179 227 56 64 105 195
2024/20255.698 148 100 113 426 1.060 954 349 308 640 317 602 681
2025/202611.645 754 456 895 1.193 1.846 771 1.562 550 1.150 999 859 610
2026/202763 63 0 0 0 0 0 0 0 0 0 0 0
Totale 31.109